Your KOL Engagement Strategy is Ineffective Against the Consolidated Health Systems of Dallas Pharma.
Your team is executing a flawless national Key Opinion Leader strategy, yet your drug’s adoption rate within the Dallas-Fort Worth metroplex is flatlining. Why? Because generic engagement tactics shatter against the institutional walls of massive, protocol-driven health systems like Baylor Scott & White and Texas Health Resources. These organizations operate with their own formularies, internal influencers, and complex value analysis committees that are impenetrable to outsiders. Stop wasting resources on a playbook that was never designed for this unique market. M.I.I. connects you with the speakers who have spent their careers on the inside—the former medical directors, formulary decision-makers, and regional VPs who built the access pathways you need. They deliver the actionable intelligence to navigate these systems, influence prescribing habits at scale, and turn institutional barriers into your most significant competitive advantage.
